Keep Alzheimer’s patients on Aricept for longer, study says
March 8, 2012Research and Development, Sales and Marketing Aricept, Pfizer, Teva, donepezil
Patients with severe forms of Alzheimer’s disease should stay on Pfizer’s Aricept for longer, according to new research. A new …
Biotec launches new operational facilities and increases temperature controlled storage
March 8, 2012Manufacturing and Production
UK based pharmaceutical services business Biotec Services International has launched a dedicated new storage and operational facility along with upgraded …
Novartis Indian patent battle nears conclusion
March 7, 2012Sales and Marketing Glivec, HIV, India, Novartis, patents
A long-running battle over the patent of cancer treatment Glivec in India is about to reach its dramatic climax.India’s Supreme …
Pfizer’s virtual trial fails in recruitment drive
March 7, 2012Medical Communications Pfizer, bladder, virtual clinic, youtube
The world’s first ‘virtual’ clinic has failed to recruit patients in the US, representing a major blow to Pfizer. The …
Sandoz falls foul of ABPI Code
March 7, 2012Medical Communications, Sales and Marketing ABPI Code of Practice, Sandoz
Sandoz has been rapped over the knuckles for offering non-approved bags and bottles to patients.It was found to be offering …
Onyx appoints Luigi Costa as its new vice president of Europe
March 7, 2012Sales and Marketing Luigi Costa, Onyx
Onyx Pharmaceuticals International has appointed Luigi Costa as vice president and head of its European division. Costa will report to …
Cancer Drugs Fund should not be used across the UK
March 7, 2012Sales and Marketing CDF, Janssen, NICE, Zytiga, myloma, prostate
The Prostate Cancer Charity has said that extending England’s Cancer Drugs Fund to the UK will not solve the issue …
NICE appoints two new directors
March 7, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mark Baker, NICE
The National Institute for Health and Clinical Excellence (NICE) has appointed two new directors. Professor Mark Baker will be the …
Can Europe really agree to speed up pricing and reimbursement?
March 6, 2012Sales and Marketing Europe, European Commission, GSK, Sir Andrew Witty, pricing and reimbursement
The European Commission has called for faster decisions to allow new medicines to enter the market faster.The Commission says the …
Web-based tool for chronic diseases launched in UK
March 6, 2012Medical Communications Curavista Health, HealthCare21, MyHealthMonitor, telecare, telehealth
A new electronic tool to help patients and their doctors monitor long-term conditions has been launched in the UK. The …
Ranbaxy launches generic Lipitor in Europe
March 6, 2012Research and Development, Sales and Marketing Lipitor, Pfizer, Ranbaxy, atorvastatin, generics
Ranbaxy has launched its generic version of Pfizer’s Lipitor in Europe, months ahead of its May expiration date. The Indian …
Using the corporate brand in pharma
March 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Marks, MSI, brand, branding, brands
In many markets the corporate brand can add significant value and values to the portfolio of product brands and franchises. …
ABPI appoints Catherine Meaden as head of policy and public affairs
March 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS Direct, VBP
The ABPI has appointed Catherine Meaden as its new head of policy and public affairs. She will join the UK …
Indian CMO will make Roche blockbusters
March 6, 2012Manufacturing and Production Emcure, Herceptin, India, MabThera, Pegasys, Roche
Roche has reportedly signed an agreement with Emcure Pharmaceuticals of India that will see the latter manufacturing its blockbuster drugs …
GSK collaborates with Dundee on neglected diseases
March 6, 2012Research and Development, Sales and Marketing Africa, Dundee, GSK, Gates, Wellcome
GlaxoSmithKline has teamed up with Dundee University and the Wellcome Trust to develop new drugs for neglected diseases. Healthcare charity …
Genzyme starts shipping Fabrazyme from Framingham facility
March 6, 2012Manufacturing and Production Fabrazyme, Framingham, Genzyme
Sanofi subsidiary Genzyme has shipped the first supplies of Fabry disease treatment Fabrazyme produced at its new plant in Framingham, …
Boehringer to invest €17m in Biberach, Vienna facilities
March 6, 2012Manufacturing and Production Austria, BI-HEX, Boehringer Ingelheim, Vienna, manufacturing
Boehringer Ingelheim has said it plans to invest around €17 million in its biopharmaceutical development and manufacturing capabilities at Biberach, …
Mundipharma appoints Paul Medeiros as head of corporate and business development
March 6, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Cambridge, Medeiros, Mundipharma
Mundipharma International has appointed Paul Medeiros as its new head of corporate and business development at its Cambridge, UK site. …
Second contraceptive recall in US for packaging errors
March 5, 2012Manufacturing and Production American Regent, Glenmark generics, McNeil Consumer
India’s Glenmark Generics has been forced to undertake a US-wide recall of seven lots of oral contraceptive product because of …
Contract research news in brief
March 5, 2012Research and Development CPR, Celeron/Ricerca, Certara, PRA, Quintiles
CPR opens first bioanalytical lab in Singapore, PRA wins an MS vaccine trial contract, plus M&A and alliance news from …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
